Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Dronabinol 2026-05-13
Germany The Goal Is To Conclude Discount Contracts For Medicinal Products According To § 130a Abs. 8 In Conjunction With § 31 Abs. 6 Sgb V For Cannabis Within The Framework Of An Open-house Procedure. The Contract Duration Is A Maximum Of 24 Months Starting From 2026-05-13
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Dexamethasone + Gentamicin, Atc S01ca21 For The Period 01.04.2026 - 31.03.2028 (plus V.-option 1x12 Months) 2026-05-13
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Rivaroxaban, Atc B01af01 For The Period 01.04.2026 - 30.06.2026 2026-05-13
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Caspofungin, Atc J02ax04 For The Period 01.04.2026 - 31.03.2028 (plus Extension Option 1x12 Months) 2026-05-13
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Dexamfetamine, Atc N06ba02 For The Period 01.04.2026 - 31.03.2028 (plus Extension Option 1x12 Months) 2026-05-13
Germany Federal State Of Berlin 2026-05-13
Germany Determination Of The Appropriateness Limits Of The Needs For Accommodation In Accordance With § 22 Sgb Ii Based On A Coherent Concept 2026-05-13
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Filgrastim, Atc L03aa02 For The Period 01.04.2026 - 31.03.2028 (plus Extension Option 1x12 Months) 2026-05-13
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Ipratropium (excl. Dafo. Lov), Atc R03bb01 For The Period 01.04.26 - 31.03.28 (plus V.-option 1x12 Months) 2026-05-13
Whats app